TrialSignal transduction and targeted therapy2026

Coronary atherosclerotic plaque intervention with Tongxinluo capsule (TXL-CAP): a multicenter, randomized, double-blind and placebo-controlled study.

Mei Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.